key: cord-0015467-lx2vk727
authors: Opo, Firoz A. Dain Md; Rahman, Mohammed M.; Ahammad, Foysal; Ahmed, Istiak; Bhuiyan, Mohiuddin Ahmed; Asiri, Abdullah M.
title: Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein
date: 2021-02-18
journal: Sci Rep
DOI: 10.1038/s41598-021-83626-x
sha: e69af8c6eca60e6c712910571c0b916704be9d69
doc_id: 15467
cord_uid: lx2vk727

X-linked inhibitor of apoptosis protein (XIAP) is a member of inhibitor of apoptosis protein (IAP) family responsible for neutralizing the caspases-3, caspases-7, and caspases-9. Overexpression of the protein decreased the apoptosis process in the cell and resulting development of cancer. Different types of XIAP antagonists are generally used to repair the defective apoptosis process that can eliminate carcinoma from living bodies. The chemically synthesis compounds discovered till now as XIAP inhibitors exhibiting side effects, which is making difficulties during the treatment of chemotherapy. So, the study has design to identifying new natural compounds that are able to induce apoptosis by freeing up caspases and will be low toxic. To identify natural compound, a structure-based pharmacophore model to the protein active site cavity was generated following by virtual screening, molecular docking and molecular dynamics (MD) simulation. Initially, seven hit compounds were retrieved and based on molecular docking approach four compounds has chosen for further evaluation. To confirm stability of the selected drug candidate to the target protein the MD simulation approach were employed, which confirmed stability of the three compounds. Based on the finding, three newly obtained compounds namely Caucasicoside A (ZINC77257307), Polygalaxanthone III (ZINC247950187), and MCULE-9896837409 (ZINC107434573) may serve as lead compounds to fight against the treatment of XIAP related cancer, although further evaluation through wet lab is necessary to measure the efficacy of the compounds.

Structure-based pharmacophore modeling and virtual screening. Pharmacophore model generation. XIAP is a nonredundant modulator of tumor necrosis factor-related apoptosis and best-defined antiapoptotic IAP family member that directly neutralizes caspase-9 via its BIR3 domain. Over-expression of the protein is responsible for developing different cancers 7 . Chemical that has developed targeting XIAP are mostly toxic and has adverse effect. Therefore, natural compounds identical to the previously originated antagonist can be developed as a drug instead of chemically synthesis compound. Ten (10) chemically synthesis active antagonist of XIAP (Table 1) were collected through ChEMBL and advance literature search, which were docked with XIAP protein. The best binding score found for the antagonist Hydroxythio Acetildenafil (PubChem CID: 46781908) was − 6.8 kcal/mol, binding energy of other 9 molecules has shown in Table 1 . Also, the interaction between XIAP protein and antagonist has provided in Table S1 .

For drug design, protein 3D structure determination is necessary and nowadays the most validated structure of protein can be mining from several protein data banks or homology modeling. To identify antagonist against desire protein crystal x-ray structure of XIAP protein (PDB: 5OQW) in complex with compound 46781908 recovered and a structure-based pharmacophore model to the enzymatic cavity was generated. Ligands binding capacity to the selected XIAP protein are determined experimentally and validated through x-ray diffraction method having IC 50 value 40.0 nM 18 . The overall expression can be regulated by binding of the inhibitor to the active site of XIAP protein. Sometimes proper efficacy of inhibitor against any protein might not be reliable due to the improper binding. So, the determination of active series of inhibitors should be examined for sufficient interaction to get more biological activity compared to the existing one. LigandScout4.3 essential advance molecular design software was used to generate the key chemical features based on pharmacophore model. The different chemical features were determined, and total number was 14. Among theme four were hydrophobics, one positive ionizable bond, three H bond acceptor, 5 H bond donor, 15 exclusion volume features were presented as a protein ligand complex interaction (Fig. 1) . To maintenance optimum pharmacophore features, some features have omitted during the time of pharmacophore model generation.

Obtained pharmacophore features generated from the protein-ligand complex is depicted that hydrophobic interactions are predominant formed with the amino acid residues of the selected protein. HBD features have been found in several interactions with the protein, whereas nitrogen atoms in the benzine ring interacted with the THR308, ASP309, GLU314 amino acid (Fig. 2) . One HBD was formed with the oxygen atom of the side chain of the amino benzine HOH523 number position. On the other site, HBD formation after ligand-protein interactions was shown as a red mark in the position of THR308, HOH556. HOH565. THR308, HOH556, which were bind to the oxygen atom, and nitrogen atom of the benzine ring bind to the HOH565. Partially two interactions such as HBD, HBA were formed also with the oxygen atom of HOH565. Positive ionizable pharmacophore features have also been found to be formed in GLU314 number position from the complex protein ligand structure. The 3D structure-based pharmacophore model of XIAP protein in complex with 46781908 (CID) ligands derived from the X-ray derived crystal structure of XIAP protein (PDB ID: 5OQW). (B) Several pharmacophore features were generated after complex interaction, four yellow spherical shapes indicating hydrophobic interaction, one blue star shape depicting the positive ionizable with tolerance 2, three red colors arrow and spherical shapes indicating H bond acceptor having tolerance 1.5, five hydrogen bond donors represented by green spherical or arrow shape have been identified within the protein-ligand complex interaction. 15 exclusion volume, which were generated during pharmacophore modeling has not showed in this schematic presentation. 20 . The AUC value is ranging between 0 and 1, so the model whose prediction rate is 100% correct has an AUC value 1. In our validation process, the early enrichment factor (EF1%) was 10.0 with an excellent AUC (area under the ROC curve) value in 1% threshold was 0.98 ( Fig. 3) , which proved that our model has ability to distinguish true actives from decoy compounds.

Dataset generation for pharmacophore-base screening. Database generation is an important part for identification the best lead molecule during screening process. ZINC database is a curated collection of commercially available chemical compounds form which we can get the information regarding compound's molecular weight, chemical structure, physical and chemical properties against biological active macromolecules. It contains more than 230 million purchasable compounds in 3D format to the freely accessible website, which is ready to dock 21 .

It also provides information regarding various compound from different vendor like Ambinter as a natural compound database library. To create the database for pharmacophore based virtual screening, the previously obtained pharmacophore model generated for each active compound was submitted to ZINCPharmer 22 . Initially, it searches hits from the ZINC database of "ZINC natural products and ZINC natural derivatives" consist millions of Drug-like, Natural Products and FDA approved drugs. A maximum of 0.5 Å RMSD from sphere centers were used as input parameters for ZINCPharmer and a total 11,000 compounds was retrieved for further screening. The database of hit compounds from the ZINCPharmer were saved and downloaded for further screening.

Pharmacophore-based virtual screening. Pharmacophore interaction features generated from the proteinligand complex was applied to the 11,000 natural compounds. During the screening process relative pharmacophore was used as a scoring function, where all query features were used as a screening mode and maximum four (4) features have omitted. It is difficult to match all of the query features during screening process that's why some features have been omitted to increase the pharmacophore fit score. A higher score is desirable for optimum fitting with the desire environment than the compound will show better activity against the targeted macromolecules. A total seven hit compound with a fit score ranging from 94.75 to 105.31 were generated that matches all of the pharmacophore features. Usually, the pharmacophore fit value is shown the geometric fit of features to the 3D-structure-based pharmacophore model. The molecule with maximum fit score to the validated pharmacophore model should show activity against our desire XIAP protein. The compound, which remarked as hit was retrieved and saved for further evaluation.

Binding site identification and receptor grid generation. Based on the crystal structure, the desire XIAP (PDB ID: 5OQW) protein was bounded with three ligands. So, the protein pockets have different attachment site as well as shape for binding the favorable ligand. The binding position of the complex structure was retrieved so that the binding site can further utilize during molecular docking simulation. Analysis of the protein-ligand interaction revealed a salt bridge at the position of GLU314, four pi-alkyl bonds formed to formed at the benzine ring and side chain of benzine ring by interacting with TRP323, TYR324, LYS297. Four conventional hydrogen bonds were formed between the ASP309 and THR308 position. One halogen bond has observed at VAL298 with the fluorine attached to the benzine ring. At the same time, two carbon-hydrogen bonds were formed at GLN319 with the two sides of the same benzine ring (Fig. 4) . (7) compounds were docked with XIAP by utilize PyRx tools Autodock vina to evaluate their binding capacity, which satisfied the characteristics of the pharmacophore model 23 . Among them, four compounds ZINC77257307, ZINC1070004335, ZINC247950187 and ZINC107434573 with binding affinity − 8.0 kcal/mol, − 7.8 kcal/mol, − 7.6 kcal/mol, and − 6.9 kcal/mol ( Table 2) , respectively shown better binding affinity than the XIAP antagonist CID: 46781908 (− 6.8 kcal/mol), that has used during main pharmacophore model generation. The binding affinity for all of hit shown in Table S2 . Interestingly, compound which have higher pharmacophore fit score ( Table 2) found higher docking score, and higher docking score indicates the better binding to the desire protein.

Here, it is observed that compound that have better pharmacophore fit score gained better binding affinity ZINC77257307 (− 8.0 kcal/mol), ZINC1070004335 (− 7.8 kcal/mol), ZINC247950187 (− 7.6 kcal/mol) and ZINC107434573 in contrast to the compound CID: 46781908 (− 6.8 kcal/mol) showed in Table 2 . ZINC77257307 formed nine van der walls interactions with LYS297, LEU292, GLY304, GLY305, TYR324, GLY306, LEU307, GLN319, LYS311, three conventional hydrogen bonds with ASP309, THR308, GLU314, one pi donor hydrogen bond with TRP310, one alkyl bond with LYS299, and two Pi-alkyl bonds with TRP323 with desire XIAP protein (Figs. 5 and 6).

In the case of ZINC1070004335 van der walls bond were predominantly formed with LYS334, TYR329, ALA263, PHE301, PRO257, ASN255, ARG268, ASP264, TYR265. The position of TRP317, GLN333, GLU332 acquired three conventional hydrogen bonds, one carbon-hydrogen bond at HIS302 and one alkyl bond with ARG286 position (Figs. 5 and 6). www.nature.com/scientificreports/ For the compound ZINC247950187, the number of vans der walls interaction has decreased but increased other types of bond such as 5 van der walls interaction at position ASP264, GLN333, PRO257, PHE301, LYS328 has found to formed, which are less than the previous two compounds. Nine conventional hydrogen bonds with ALA263, ARG268, HIS302, GLU332, ASN255 position with four hydrogen atom, one pyridine, and one benzene ring with ARG268 and ALA263 position has found to formed (Figs. 5 and 6). For, ZINC107434573 it has observed to formed five carbon-hydrogen bonding in the position of ASN255, HIS302, GLU332, one pi-sigma with TYR265, one pi-pi t shaped bond with TYR329, one alkyl and pi alkyl bond with ARG286. The compounds also produced 11 van der walls bond with GLY305, PRO251, TYR324, PHE250, TRP323, LYS322, GLN319, GLU314, TRP310, ASP309, LEU307, and 3 conventional hydrogen bonds with ASN249, GLY306, THR308 position. The protein-ligand interaction mode for all the four compounds has listed in Table 3 .

Pharmacophore is a group of steric and electronic features that confirm optimal supramolecular interactions during virtual screening on large scale compound databases. It is powerful and more efficient method than molecular docking that can find molecules against specific target to induce or inhibit the macromolecular activity 24 . The compound which has similar or relevant properties should show the same or better activity like to the query compound. In this study, the top four compounds (based on docking score) ZINC77257307, ZINC1070004335, ZINC247950187 and ZINC107434573 pharmacophore features was analyzed and compared with the features of the antagonist 46781908. All of the compounds have better pharmacophore properties than the antagonist CID: 46781908, so these compounds should be effective to our target protein. The pharmacophore feature found of the four compounds has shown in Fig. 7 .

Analysis of ADME properties. After administration of the drug through any route to the human body or in the animal model, it undergoes the absorption, distribution, metabolism, excretion resulting active or passive transport to the target site 25 . Interaction with the target biological macromolecules might produce desirable or undesirable pharmacological effect. Drug design is a step-by-step evaluation process and lacking the evaluation my reason for rejection of the drug, which is costly for any companies. The bioavailability of a drug depends on the safety and efficacy, lack of safety and efficacy are the main cause of drug failure, which are mainly depend on the ADME properties. Here, we evaluate the ADME properties of the selected four compounds by using in silico SwissADME server to see the pharmacokinetic properties such as lipophilicity, water-solubility, drug-likeness, medicinal chemistry of the compounds 26 . The lipophilicity of compounds means they can easily diffuse through the cell membrane; hence the oral preparation is not suitable. Moreover, an injectable dosage form may be a www.nature.com/scientificreports/ better option to get a rapid onset of action as the gastrointestinal absorption is low. The ADME properties of the selected four compounds has shown in Table 4 .

For better lead compound selection, in-silico toxicity measurement is an important procedure before drug candidate undergo clinical trial 25 . Computational based in-silico toxicity measurement has been widely used due to their accuracy, rapidity, accessibility, which can provide information about any synthesis or natural compounds. To identify the toxicity and adverse effect of the selected four compounds, we used both freely accessible TEST tool 27 , and ProTox-II server 28 . Each software was used to evaluate several toxicological parameters such as acute toxicity, hepatotoxicity, cytotoxicity, carcinogenicity, mutagenicity, immunotoxicity, and the result was achieved based on predicted median lethal dose (LD 50 ) in mg/kg weight (Table 5 ). According to the ProTox-II server compound ZINC107434573 and ZINC247950187 both were belonging to class 4, LD 50 range from 300 to 2000 mg/kg, these would be harmful in case of oral delivery. For ZINC1070004335, the LD 50 value was less than < 50 mg/kg, so oral intake might be toxic or fetal, which were belongs to the toxicity class two in ProTox-II. ZINC77257307 was in the toxicity class 6 and the LD 50 value was also more than 5000 mg/kg and it is also nontoxic but having some immunotoxicity. 

MD simulation is used to explore the binding stability of protein-ligand docking complexes 29 . The MD simulation also provide information regarding intermolecular interaction within a reference time. Herein, the complexes docking file of selected four natural compounds and one reference antagonist bind with XIAP protein were analyzed by utilize MD simulation approaches to confirm the stability and intermolecular interactions between protein and molecules against 50 ns time interval. Trajectories of MD were extracted by utilize SID in Maestro-Desmond interface and the simulation result has described based on RMSD, RMSF and Protein-Ligand (P-L) interaction mapping.

Root mean square deviation (RMSD) in MD simulation is used to measure the average distance generated by displacement of a selected atoms for a specific time frame with respect to a reference time frame 14 . Initially, RMSD value of specific protein structure such as Cα, backbone, sidechain and heavy atoms are computed, after that RMSD of the protein fit ligand from all the time frames during the reference time (in our case 50 ns) is calculated. RMSD for frame x can be calculated from the following equation (Eq. 1). 

Based on RMSD result, it can be determined that simulation has equilibrated or not. Fluctuations between 1-3 Å within a reference protein structure is perfectly acceptable, where much larger value indicate large conformational change of the protein and the system is not stable. Analysis of our four protein-ligand docking complex found Cα atoms of XIAP showed acceptable fluctuations < 3 Å, except in XIAP-ZINC1070004335 complex. The compound ZINC1070004335 exhibited an extended variation 5.1 Å and a maximum fluctuation 8.81 Å (between 26 and 28 ns) observed during 50 ns simulation run (Fig. 8) . From the data we can assume that XIAP undergo protein conformation changes influence by the binding of ZINC1070004335.

RMSD of ligand. Furthermore, analysis of RMSD from the data obtained from protein fit ligands showed minimum variations (< 3 Å), except for ZINC1070004335 complex (> 4.84 Å) at the end of 50 ns simulation interval (Fig. 9) . However, it is necessary to mention that three natural compound ZINC77257307, ZINC247950187, ZINC107434573 www.nature.com/scientificreports/ and the chemical antagonist CID: 46781908 docked with XIAP exhibited equilibrium within 10 to 15 ns, with an exception for XIAP-ZINC1070004335 complex, which has tried to exhibited state of equilibrium after 25 ns.

and determination the local conformational change in the protein chain and the compounds utilized as ligand 14 .

The RMSF of the residue i can be calculated by the following equation (Eq. 2).

Here, T can define as the trajectory time; tref is the reference time, and r' define the location of the selected atoms within the residue i after superimposing on the reference frame, and (< >) expressed the average of the square distance taken over residue b.

The local structural fluctuations of XIAP protein in complex with natural compound were calculated by using the deviations contributed by residues index Cα. Interestingly, residues for all protein have found a minimum RMSF values, except in N-terminal minimum 4.18 Å to maximum 12.16 Å (Fig. 10) . So, analysis of RMSF and RMSD value for all protein-ligand complex supported the combined screened potential compounds except compound ZINC1070004335 against XIAP protein.

Protein-ligand contact occur through hydrogen bonding, ionic bonding, water bridges and hydrophobic bonding play an important role to design a molecule into effective drug. Protein-ligand contact occurred to XIAP protein and selected four natural compounds were analyzed from the MD trajectories by using default parameters of Desmond module. All the selected natural compounds ZINC77257307, ZINC247950187, ZINC107434573 and ZINC1070004335 showed tangible contact with most of the protein residues (Fig. 11) , i.e., ASN 249 and LYS 299 except compound ZINC247950187 but maintain optimum binding with other residue like GLU 332 of the XIAP protein. Interestingly, the residue GLU332 were also found in the respective ligand-protein complex docking structure of the selected compounds (Table 3) . Moreover, the four compounds screened through different filtering process exhibited considerable intermolecular interaction.

In this in-silico approach, three new natural compound ZINC77257307, ZINC247950187, and ZINC107434573 have discovered that may be able to induce apoptosis through freeing up caspases. These selected compounds have a higher binding affinity ranging between − 6.9 and − 8.0 kcal/mol with desire XIAP protein. Based on the in-silico toxicity test, they have found a lower toxicity, and ADME analysis determined the easily absorbability to the tissue site, which is readily fat soluble. Initially, a structure-based pharmacophore model was developed following by virtual screening, molecular docking, ADMET analysis and MD simulation. Four compounds were reached at the last step until MD simulation, but stability of the compound ZINC1070004335 was unfavorable to the protein XIAP in MD simulation, which has rejected. The top three natural compound that exist during the A-to-Z virtual screening process may serve as lead molecules to fight against cancer.

Structure-based pharmacophore modeling and virtual screening. Structure-based pharmacophore modeling. The active antagonists of X-linked inhibitor of apoptosis protein (XIAP) were generated by collecting all available target annotations from ChEMBL (on the basis of high-confidence activity data) and extensive literature search 30 . In order to generate a structure-based pharmacophore models, the 10 active antagonists (Table 1) obtained from ChEMBL (https ://www.ebi.ac.uk/chemb l/) and literature search have docked with the XIAP (PDB ID: 5OQW) protein by utilizing the PyRx AutoDock Vina option based on scoring functions. The best compound with highest binding affinity (kcal/mol) was selected for structure-based pharmacophore modeling. Top scoring compound in complex with XIAP protein was used to interact with the natural compounds resulting retrieval of hits. LigandScout 4.3 advance software was used to produce a structure-based pharmacophore model 31 . This advanced software works by making the interaction between inhibitors and critical amino acids of the active sites in our target protein. This software interprets ligand-receptor interaction with different pharmacophore features such as hydrogen bond donor, charge transfer, hydrophilic and hydrophobic regions, and hydrogen bond acceptors. We have detected other features using stepwise algorithms such as the number of aromatic rings, hybridization state, the pattern of binding, the distance of receptor molecules 32 . For identify better and optimum compound structure, we deleted hydrophilic properties from the protein by using ligand scout, excluded or included features to the active site necessary to maintain sterically circumference of the macromolecule.

Pharmacophore model validation. Pharmacophore validation helps to evaluate the potential features of active and inactive compounds usually can be obtained from specific protein-ligand interaction 33 . Pharmacophore model generated from the protein-ligand complex was validated for its performance to distinguish active compounds from decoys by screening a set of 10 known actives and correspondence 5199 decoy correspondence obtained from DUD-E decoys database 34 . The ten active antagonists obtained from ChEMBL (https ://www.ebi. ac.uk/chemb l/) was remarked as "active" against XIAP, which was experimentally validated that's why the compounds have chosen for further experiment. The database from DUD-E was converted in the .ldb format before screening by the "create screening database" menu of LigandScout 4.3 31 . Here, it has been assessed the quality of the structure-based model based on the GH score and early enrichment factor (EF).

(2) www.nature.com/scientificreports/ Dataset Generation for pharmacophore-base screening. It can be identified the structurally novel and active molecules by the completion of virtual screening depending on the generated pharmacophore model 35 . ZINC (https ://zinc.docki ng.org/) is a freely available chemical database, which is being utilized to identify the potential lead compounds 21 . Compounds from the database can be searched depending on the structure, name of the compound, or using the chemical smile ID. Physical and chemical properties such as 2D and 3D structure determination, the boiling point, the melting point were analyzed. Molecular weight, crystal structure, and biological application information can be also obtained of the desired compound. In the case of the desired compound, it has given priority, the compound having the most similar features matches the required pharmacophore features and can easily interact with our target protein. It has been chosen the possible hit compounds whose maximum features were matched to query pharmacophore. For the study, initially we have screened ZINC natural product library by using ZINCPharmer (http://zincp harme r.csb.pitt.edu/pharm er.html) server for target XIAP based on pharmacophore features 22 .

Pharmacophore-based virtual screening. Database generated from ZINCPharmer was subject to screen against the validated structural based pharmacophores features. LigandScout 4.3 advanced help to make and getting a 3D model in case of protein-ligand interaction and worked to change compounds into the specific (idb) file format. These compounds were passed directly into the database list for quick pharmacophore features based virtual screening. The securitizing has been completed by selecting relative pharmacophore-fit as a getting few functions based on omitting some features more than 2. Fitted hit compounds were arranged based on the pharmacophore fit score and subject to further validation.

Protein and ligand preparation. Protein preparation in computational biology is a process by which macromolecular structure are converted into more suitable form for a computational experiment 36 . Prior to docking crystal structures of protein is needed to prepare which are not part of the x-ray crystal structure refinement process such as addition and optimization hydrogen bonds, remove atomic clashes, and perform other operations. For the study, desired 3D structure of XIAP protein was obtained from the protein data bank (PDB ID: 5OQW), which was determined experimentally and validated through X-ray diffraction method having resolution 2.31 Å and R-value free score 0.246 that is significantly less than standard value 0.25. The X-ray crystallography structure of our desire protein was prepared by the following steps (i) water, metal ion and cofactors were removed, (ii) polar hydrogen bond was added and non-polar H was merged and (iii) gasteiger charges were calculated by using AutoDockTools (ADT) 1.5.6 36, 37 . Selected hit compounds reterived from Ligandscout was prepared and the energy was minimized and bond angle was opitimized by default of the Universal Force Field (UFF) for each ligand.

Active site identification and grid generation. Binding of ligand or drug molecules to the specific site of protein is the key strategy to treat a particular disease. Improper attachment of ligand may show several side effects in the body with higher possibities of toxicities also 38 . These bininding affinities depend on several features H bond donars, hydropohobic or hydrophilic interaction, ionization, chelation of zinc compound. In the study, we used BIOVA Discovery Studio Visualizer Tool 16.1.0 to find the binding site of our desire protein.

Moreover PrankWeb (https ://prank web.cz/) server was used to analyze the all probable binding site of the desire protein structure 39 . The server utilizes novel machine learning-based method for prediction of ligand binding sites from protein structure. Receptor grid was generated after selection of the active site of protein by using the PyRx software.

Molecular docking. Selected hits compounds obtained by pharmacophore screening were subject to molecular docking, which was carried out by PyRx virtual screening software. In computational biology, PyRx is utilize as a virtual screening software that has identified many potential drug candidate against several diseases 40 

Absorption, distribution, metabolism and excretion (ADME). Evaluation of Absorption, Distribution, Metabolism and Excretion (ADME) properties is one of the major criteria before developing molecule into a drug 29, 42 . Previously many drug candidate could not fit the clinical trial demand and so the computer-based prediction is important for the early stage of prediction. Physiochemical properties, hydrophobicity, lipophilicity, gastrointestinal environment, blood brain barrier are directly affected by the ADME profile before the excretion of drug from body through urine and feces 43 . The freely accessible Swiss-ADME (http://www.swiss adme. ch/) server was used to evaluate the ADME properties such as solubility profile, GIT absorption, bioavailability profile of the selected compounds 26 .

Toxicity test. Computational based approach has made it possible to measure the toxicity by in silico methods for accessing the safety profile of the desired compounds. Otherwise, these compounds may show the harmful effect on human and animals. Toxicity profile can evaluate and determine the mutagenicity, carcinogenicity, LD 50 value, immunotoxicity in both quantitatively and qualitatively 44 www.nature.com/scientificreports/ is freely accessible software, which was used in this study to estimate toxicity of our compounds without requiring any other external programs 27 . The toxicity estimator TEST tools are being used for selective molecules that is work based on Quantitative Structure-Activity Relationships (QSARs) methodologies. Additionally, ProTox-II (http://tox.chari te.de/proto x_II) server was used to determine the toxic effect of the selected four compounds 28 . Different toxicological pathways including nuclear receptor signaling pathways, stress response pathways can be obtained from this site.

Explicit-solvent MD simulation. In order to further evaluate of protein toward the binding mode of our candidate molecules, the best poses obtained from re-docking studies were evaluated through 50 ns molecular dynamics (MD) simulations for measuring the complex stability. The MD simulations was carried out by using Desmond module in Schrödinger Release 2020-3 (Academic version) suite under Linux environment [÷45 . The complex protein-ligand interaction was first solvated with simple point charge (SPC) water model with boundary condition orthorhombic box shape. Buffer box calculation method with box distance 15 Å (a = 5 Å, b = 5 Å, and c = 5 Å) on both side for all of the complex's atoms has assigned. The system was neutralized by adding Na + and Clwith a salt concentration 0.15 M. NPT ensemble was performed at constant pressure (1.01325 bar) and temperature (300 K) with recoding intervals 50 ps with energy 1.2, where OPLS-2005 force field was utilized to carried out the MD simulation.

Post-dynamics trajectory analysis. The trajectories generated after completing the MD simulation were further analyzed by using Simulation Interaction Diagram (SID) of Desmond module in Schrödinger package. Based on the simulation's trajectories, the stability of the ligand-protein complexes was determined according root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF) and Protein-Ligand contacts.

Received: 11 December 2020; Accepted: 5 February 2021

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

Non-coding RNAs in various stages of liver disease leading to hepatocellular carcinoma: differential expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno

Hepatocellular carcinoma: a comprehensive review

Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer

High expression of bone morphogenetic protein 1 (BMP1) is associated with a poor survival rate in human gastric cancer, a dataset approaches

Stem cells, cancer, and cancer stem cells

X-linked inhibitor of apoptosis inhibits apoptosis and preserves the blood-brain barrier after experimental subarachnoid hemorrhage

X-linked inhibitor of apoptosis (XIAP)-a critical death-resistance regulator and therapeutic target for personalized cancer therapy

X-linked Inhibitor of Apoptosis Protein negatively regulates neuronal differentiation through interaction with cRAF and Trk

The structure of XIAP BIR2: understanding the selectivity of the BIR domains

Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP

Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain

In silico drug discovery: tools for bridging the NCE gap

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach

Molecular docking: a powerful approach for structure-based drug discovery

Anti-inflammatory, antinociceptive and antidiarrhoeal activities of methanol and ethyl acetate extract of Hemigraphis alternata leaves in mice

Structure-based drug design to augment hit discovery

ASTX660, a novel non-peptidomimetic antagonist of cIAP1/2 and XIAP, potently induces TNFα-dependent apoptosis in cancer cell lines and inhibits tumor growth

Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening

Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors

ZINC 15-ligand discovery for everyone

Pharmacophore search of the ZINC database

Small-molecule library screening by docking with PyRx

Virtual Screening, pharmacophore development and structure based similarity search to identify inhibitors against IdeR, a transcription factor of Mycobacterium tuberculosis

In silico ADME and toxicity prediction of ceftazidime and its impurities

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

A hierarchical clustering methodology for the estimation of toxicity

ProTox-II: a webserver for the prediction of toxicity of chemicals

Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in brucella melitensis 16M. Drug Des

ChEMBL: Towards direct deposition of bioassay data

LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters

An improved receptor-based pharmacophore generation algorithm guided by atomic chemical characteristics and hybridization types

Pharmacophore modeling in drug discovery and development: an overview

Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking

Synthesis and biological evaluation of new homocamptothecin analogs

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors

Local alignment of ligand binding sites in proteins for polypharmacology and drug repositioning

CASTp 3.0: computed atlas of surface topography of proteins

User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation

Virtual screening: a fast tool for drug design

2D and 3D-QSAR, molecular docking and ADMET properties: In silico studies of azaaurones as antimalarial agents

In silico approaches for predicting ADME properties of drugs

In silico toxicology: computational methods for the prediction of chemical toxicity

Scalable algorithms for molecular dynamics simulations on commodity clusters

This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) -King Abdulaziz City for Science and Technology -the Kingdom of Saudi Arabia -award number (14-BIO1978-03). The authors also, acknowledge with thanks Science and Technology Unit, King Abdulaziz University for technical support. We thank also Abdus Samad and Rahat Alam, BioSol Centre (www.bioso lcent re.org) for their support in molecular dynamics simulation.

The authors declare no competing interests.

The online version contains supplementary material available at https ://doi. org/10.1038/s4159 8-021-83626 -x.Correspondence and requests for materials should be addressed to M.M.R.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.